In one study (Tunovic et al., 2014), clinical features are hypothesized to result from the combined effect of mutations in KDM1A and ANKRD11 (Ankrin Repeating Domain-Containing protein 11), the latter of which is associated with KBG syndrome involving craniofacial phenotypes. Here, KDM1A is linked to KBG syndrome.